Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUETTO: 4-Day vs 7-Day Antiretroviral Dual Therapy in HIV-1
NCT04867083Phase 3Unknown
- Sponsor
- ANRS
- Start
- Jun 2021
- Primary completion
- Jul 2023
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial in human immunodeficiency virus infection (HIV) (2 arms), sponsored by ANRS. Primary endpoint: Proportion of patients with virological failure at Week 48. Status: unknown.
02
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04867083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04867083.